- Home
- PMVP vs MDCX Comparison
PMVP vs MDCX Comparison
Compare PMVP & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.56
Company Overview
Basic Information| Metric | PMVP | MDCX |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | N/A | 12 |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.8M | 26.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PMVP | MDCX |
|---|---|---|
| Price | $1.56 | $0.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $5.00 | ★ $23.50 |
| AVG Volume (30 Days) | 815.0K | ★ 8.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.82 | $0.37 |
| 52 Week High | $1.88 | $8.90 |
Technical Indicators
Market Signals| Indicator | PMVP | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 60.27 | 31.96 |
| Support Level | $1.32 | $0.37 |
| Resistance Level | $1.56 | $1.43 |
| Average True Range (ATR) | 0.14 | 0.19 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 60.71 | 11.47 |
Price Performance
Historical Comparison PMVP
MDCX
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.